Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
periodontitis pharyngitis gingivitis amalgam fluoride mutans pulp candidiasis pulp malocclusionYour Article Summary
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis
Critical Reviews in Oncology/Hematology, 06/11/09
Tubiana-Hulin M et al. - Dental procedures could worsen the risk of ONJ, and indications must be well evaluated. When an ONJ occurs, the management should be adapted according to its extent. Thereby, a customization of BP therapy should be applied taking into account the aggressiveness of the underlying disease.
Today in OMF Pathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
Oral Oncology , 10/21/09
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Journal of Clinical Oncology, 10/12/09
Article Search
Sponsor


See Latest Articles


